AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity-Reference-Cited by-同舟云学术

AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity

Published:2022-11 Issue:5 Volume:163 Page:1198-1225
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Grunvald Eduardo,Shah Raj,Hernaez Ruben,Chandar Apoorva Krishna,Pickett-Blakely Octavia,Teigen Levi M.,Harindhanavudhi Tasma,Sultan Shahnaz,Singh Siddharth,Davitkov Perica

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference166 articles.

1. Prevalence and trends in obesity among US adults, 1999–2000;Flegal;JAMA,2002

2. Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. National Center for Health Statistics. Published June 14, 2021. Available at: https://doi.org/10.15620/cdc:106273. Accessed August 28, 2022.

3. Trends in obesity prevalence among adults aged 18 through 25 years, 1976-2018;Ellison-Barnes;JAMA,2021

4. Changes in the incidence of childhood obesity;Cunningham;Pediatrics,2022

5. Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials;Dombrowski;BMJ,2014

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database;BMC Pharmacology and Toxicology;2024-09-12

2. Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective Study;Cureus;2024-09-11

3. Polypeptides-Based Nanocarriers in Tumor Therapy;Pharmaceutics;2024-09-10

4. Anthropometric indicators and cardiovascular diseases risk in pre-diabetic and diabetic adults: NHANES 1999–2018 cross-sectional analysis;Experimental Gerontology;2024-09

5. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09